Showing results (571-580 of 602) with videos related to
Sort By:
Pageof 61
Psychological Medicine|October 8, 2013
The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) studyR Sprengelmeyer, M Orth, H-P Müller, et al.Clinical Genitourinary Cancer|May 11, 2021
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched AnalysisMarina Deuker, Marieke J Krimphove, L Franziska Stolzenbach, et al.The Journal of Clinical Endocrinology and Metabolism|February 8, 2007
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early pubertySandy A van Gool, Gerdine A Kamp, Hanneke Visser-van Balen, et al.ESMO Open|May 17, 2025
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA studyT Decker, C Brucker, A Engel, et al.Brain Stimulation|August 16, 2017
The reliability of commonly used electrophysiology measuresK E Brown, K R Lohse, I M S Mayer, et al.Journal of Huntington'S Disease|July 27, 2014
Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's DiseaseEve M Dumas, Miranda J Say, Rebecca Jones, et al.Ebiomedicine|December 3, 2015
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD StudyStefan Klöppel, Sarah Gregory, Elisa Scheller, et al.Bone|November 30, 2013
Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocolMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.Plos One|July 7, 2015
Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier GeneLeire Valcárcel-Ocete, Gorka Alkorta-Aranburu, Mikel Iriondo, et al.EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.Pageof 61